Beta Bionics, Inc Common Stock

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$27,626
$32,121
$27,253
$23,238
Gross Profit
16,437
18,944
15,119
12,503
EBITDA
-24,271
-15,405
-13,526
-16,216
EBIT
-13,465
-14,209
-16,869
Net Income
-21,895
-13,466
-14,209
-16,869
Net Change In Cash
27,626
32,121
27,253
23,238
Free Cash Flow
-25,209
-10,530
-10,011
-15,373
Cash
30,206
31,676
38,485
35,075
Basic Shares
44,436
40,529
43,634
43,390

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$100,251
$65,124
$11,995
$179
Gross Profit
55,537
35,888
6,308
179
EBITDA
-73,199
-44,100
-34,624
-63,399
EBIT
-45,251
-35,850
-64,744
Net Income
-73,200
-54,756
-44,099
-64,751
Net Change In Cash
100,251
65,124
11,995
179
Free Cash Flow
-56,222
-51,668
-32,847
-60,980
Cash
31,676
30,432
26,566
27,675
Basic Shares
40,529
6,365
5,303
4,997

Earnings Calls

QuarterEPS
2026-03-31
-$0.35
2025-12-31
-$0.30
2025-09-30
-$0.33
2025-06-30
-$0.39